RETRACTION OF: A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition

Authors:

Abstract
No abstract available
Funding Information
  • National Institute on Aging
  • National Institutes of Health (R21AG049477)
  • National Institutes of Health (R01AT007411)
  • National Institutes of Health (R01AG050253)

This publication has 50 references indexed in Scilit: